NOVEL LACTOBACILLUS PARACASEI GKS6 FOR MITIGATING METABOLIC SYNDROME, CULTURE MEDIUM THEREOF, CULTURE METHOD, USE, PHARMACEUTICAL COMPOSITION, AND EDIBLE COMPOSITION

摘要

Provided is novel Lactobacillus paracasei GKS6 for mitigating metabolic syndrome, having an access number of CGMCC No. 14566. Also provided are a culture medium of a GKS6 strain, a culture method, use, a pharmaceutical composition, and an edible composition. A GKS6 strain is acid-resistant and bile salt-resistant, can effectively reduce the weight, reduce organ hypertrophy, lower liver lipid content, lower blood lipid, reduce liver enlargement, reduce liver function index, lower visceral adipose tissue and/or subcutaneous adipose tissue content, and remove body fat, and can be used for preventing and/or treating metabolic syndrome-related diseases, reducing obesity caused by high fat diet, and increasing the discharge of in-vivo fat to reduce obesity caused by high fat diet.